The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
You must be logged in and own this session in order to
post comments.
Leo OzurumbaDwight
1/13/21 9:34 am
Good day sir.
Please how did your team take care of ADE antibody dependent enhancement, to ensure it is negated as effect from this vaccine ?
Was BNT162b2 mRNA designed to take care of mutations that led to Sarscov-2 mutants such as B.1.1.7 UK mutant and 501.V2 mutant ?
The key muttion in 501.V2 South African mutant presents a key mutation in spikenororein called E484K. This mutation is reputed to reduce antibody recognition.This enhances progression of diseases, create windows for possible rapid spread and can be a source of concern to developed vaccines.
Has this BNT162b2 mRNA been designed to neutralize this problem and shrug it off to enhance long lasting protection ? Or do we have a challenge in our hands that requires us LL to wait for some months and see how these current 3 vaccines from Pfizer-BioN Tech, Moderna and Astra Zeneca-Oxford University cope ?
Good luck, thank you and I comments your efforts at BioN Tech.
Your efforts at BioN Tech is commendble.
Warm regards sir.
Thank you.
Leo Ozurumba-Dwight.
Walden University MN US
Leo OzurumbaDwight
1/13/21 9:34 am
Good day sir. Please how did your team take care of ADE antibody dependent enhancement, to ensure it is negated as effect from this vaccine ? Was BNT162b2 mRNA designed to take care of mutations that led to Sarscov-2 mutants such as B.1.1.7 UK mutant and 501.V2 mutant ? The key muttion in 501.V2 South African mutant presents a key mutation in spikenororein called E484K. This mutation is reputed to reduce antibody recognition.This enhances progression of diseases, create windows for possible rapid spread and can be a source of concern to developed vaccines. Has this BNT162b2 mRNA been designed to neutralize this problem and shrug it off to enhance long lasting protection ? Or do we have a challenge in our hands that requires us LL to wait for some months and see how these current 3 vaccines from Pfizer-BioN Tech, Moderna and Astra Zeneca-Oxford University cope ? Good luck, thank you and I comments your efforts at BioN Tech. Your efforts at BioN Tech is commendble. Warm regards sir. Thank you. Leo Ozurumba-Dwight. Walden University MN US